12649 - Postdoctoral Research Associate
| Dyddiad hysbysebu: | 18 Mehefin 2025 |
|---|---|
| Cyflog: | £40,497 i £48,149 bob blwyddyn, pro rata |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 16 Gorffennaf 2025 |
| Lleoliad: | Edinburgh, Scotland |
| Gweithio o bell: | Ar y safle yn unig |
| Cwmni: | University of Edinburgh |
| Math o swydd: | Cytundeb |
| Cyfeirnod swydd: | 12649 |
Crynodeb
The Hardwick (https://biology.ed.ac.uk/hardwick) and Jeyaprakash (https://biology.ed.ac.uk/jeyaprakash) groups at the University of Edinburgh and the Sanyal (https://molecularmycologylab.wixsite.com/kaustuv) group at JNCASR, Bengaluru, have received significant funding to study non-canonical mechanisms of genome transmission in the human fungal pathogen, Cryptococcus neoformans.
We are seeking a postdoctoral scientist to join our interactive research programme.
You will study mechanics and/or regulation of cell division and chromosome segregation, including fascinating aspects of both polyploidy and aneuploidy, using a range of live-cell microscopy, genome engineering, structural biology and OMICS approaches.
This PDRA position in the Hardwick group is fixed-term (for 3 years) and full-time (35 hours per week), however, we are open to considering part-time or flexible working patterns.
The salary for this role is at Grade UE07: £40,497 - £48,149 per annum, pro-rata if part-time.
For an overview of our recent research see: https://doi.org/10.1371/journal.pgen.1011552; https://doi.org/10.1371/journal.pgen.1011302; https://doi.org/10.1126/science.ado8270; https://doi.org/10.1038/s44319-024-00183-w; https://doi.org/10.1038/s41467-025-56876-w; https://doi.org/10.1101/2022.09.21.508923. Research in the Institute of Cell Biology is directed towards an understanding of the molecular mechanisms that underpin genomic and cellular structure and function. It consists of around 36 research groups, including the newly formed Centre for Cell Biology and the Discovery Research Platform. Our programme is funded by the Wellcome Trust for a period of 8 years.
Your skills and attributes for success should include a PhD with experience of one or more of:
fungal pathogen biology, including CRISPR-mediated genome engineering
microfluidics, live-cell imaging, super-resolution and/or expansion microscopy
Cryptococcus neoformans infection models
protein complex purification, followed by structural and functional analyses
whole genome-sequencing and/or quantitative mass spectrometry.
We are seeking a postdoctoral scientist to join our interactive research programme.
You will study mechanics and/or regulation of cell division and chromosome segregation, including fascinating aspects of both polyploidy and aneuploidy, using a range of live-cell microscopy, genome engineering, structural biology and OMICS approaches.
This PDRA position in the Hardwick group is fixed-term (for 3 years) and full-time (35 hours per week), however, we are open to considering part-time or flexible working patterns.
The salary for this role is at Grade UE07: £40,497 - £48,149 per annum, pro-rata if part-time.
For an overview of our recent research see: https://doi.org/10.1371/journal.pgen.1011552; https://doi.org/10.1371/journal.pgen.1011302; https://doi.org/10.1126/science.ado8270; https://doi.org/10.1038/s44319-024-00183-w; https://doi.org/10.1038/s41467-025-56876-w; https://doi.org/10.1101/2022.09.21.508923. Research in the Institute of Cell Biology is directed towards an understanding of the molecular mechanisms that underpin genomic and cellular structure and function. It consists of around 36 research groups, including the newly formed Centre for Cell Biology and the Discovery Research Platform. Our programme is funded by the Wellcome Trust for a period of 8 years.
Your skills and attributes for success should include a PhD with experience of one or more of:
fungal pathogen biology, including CRISPR-mediated genome engineering
microfluidics, live-cell imaging, super-resolution and/or expansion microscopy
Cryptococcus neoformans infection models
protein complex purification, followed by structural and functional analyses
whole genome-sequencing and/or quantitative mass spectrometry.